EmoKit Tech Competitors

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into the clinic. With an extensive portfolio of highly predictive disease models and unparalleled experience performing studies for biopharmaceutical companies of all sizes, we enable clients to deliver much needed superior clinical candidates to patients. Our capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. We offer a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.

HeartMath Inc., is recognized as one of the world’s foremost authorities on HRV, Heart Coherence, emotional physiology, workplace stress and optimal employee performance. For more than 30 years, HeartMath Inc and the HeartMath Institute has been researching the heart-brain connection. As a cutting-edge performance company, we offer a range of unique services, products, and technologies to improve health and well-being, while dramatically reducing stress and boosting performance and productivity. HeartMath offers highly effective, practical solutions for increasing employee performance, reducing workplace stress, anxiety, depression and sleeplessness, and increasing resilience, productivity and performance. HeartMath certification programs offer corporations, healthcare professionals, health care institutions, leadership, human resources and staff development trainers, wellness, lifestyle, and sports coaches and personal and professional mentors a highly desirable skill set that can position themselves for client growth. HeartMath’s award-winning Inner Balance and emWave technologies have more than 300,000 users. Most recently, HeartMath released the HeartMath App where users can see and experience heart coherence in real-time. Heart rate variability (HRV) biofeedback helps you access, a healthy and high-performance state called heart coherence which balances your mind and emotions. This helps prevent stress and clears your thinking for more effective choices.

Empatica is a full-stack digital health company and an MIT spin-off, with offices in Boston (MA), Milan (Italy), and Seoul (South Korea). We specialize in the development, production, and deployment of medical-grade wearables and digital biomarkers, powered by an AI-driven platform designed for continuous health monitoring and the early detection of medical conditions. The FDA-cleared Empatica Health Monitoring Platform consists of the medical-grade EmbracePlus and EmbraceMini wearables and the world’s largest selection of validated digital measures, enabling thousands of institutional partners to remotely collect patient health data, in trials and studies on sleep, stress, epilepsy, and more. Empatica’s Embrace wearable was the world’s first FDA-cleared smartwatch in neurology to detect epileptic seizures. In 2024, we launched its successor, EpiMonitor, with all of the most loved features of Embrace and even more. EpiMonitor is an all-in-one wearable and smartphone application solution for detecting possible generalized tonic-clonic seizures, alerting caregivers during emergencies, and monitoring epilepsy. It is the only FDA-cleared wrist-worn wearable and app combination for epilepsy monitoring in the US.